TrialBMC cancer2011

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).

Stefan Heinrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.